🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Erlotinib may stop the growth of tumor cells by blocking the enzymes necess...
Status
Terminated
Location
University of Chicago Comprehensive Cancer Center
Start Date
2002-05
Trial ID
NCT00042835
The goal of this clinical trial is to learn if immunotherapy in combination...
Status
Recruiting
Location
Fudan University Shanghai Cancer Center
Start Date
2024-11-01
Trial ID
NCT06676449
The purpose of this study is to investigate the impact of combining Nimotuz...
Status
Active Not Recruiting
Location
Baotou Cancer Hospital
Start Date
2021-05-15
Trial ID
NCT06879691
Treatments Being Tested
This trial aims to evaluate the efficacy and safety between radiotherapy al...
Status
Unknown
Location
Department of Radiation Oncology, Tianjin Medical University Cancer Hospital
Start Date
2012-01
Trial ID
NCT01745445
Treatments Being Tested
This is a non-inferiority, multicenter, randomized phase 3 trial aimed to e...
Status
Recruiting
Location
Dongguan People's Hospital
Start Date
2026-07-24
Trial ID
NCT07661771
Esophageal cancer is a common and fatal malignancy. It is the eighth most c...
Status
Completed
Location
National Cheng Kung University Hospital
Start Date
2015-04
Trial ID
NCT02423811
Treatments Being Tested
This phase I trial studies the side effects and best dose of radiation ther...
Status
Terminated
Location
Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium
Start Date
2011-10
Trial ID
NCT01411098
This study pioneers a novel approach by integrating a new auxiliary chemo-i...
Status
Recruiting
Location
Beijing Tongren Hospital Affiliated to Capital Medical University
Start Date
2024-12-01
Trial ID
NCT06725498
Treatments Being Tested
This is a phase 2, single-arm clinical trial, with the purpose to evaluate ...
Status
Completed
Location
Chongqing University Cancer Hospital
Start Date
2022-01-01
Trial ID
NCT05213884
Treatments Being Tested
This is a phase I, open-label trial that will utilise a Time To Event Conti...
Status
Completed
Location
Western General Hospital, NHS Lothian
Start Date
2020-12-07
Trial ID
NCT04648033
Treatments Being Tested